Related references
Note: Only part of the references are listed.Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors
Konrad H. Stopsack et al.
CLINICAL CANCER RESEARCH (2022)
Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration
Rana R. McKay et al.
CANCER (2021)
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
Walter Rayford et al.
COMMUNICATIONS BIOLOGY (2021)
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update
Isaac J. Powell et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
David Conti et al.
NATURE GENETICS (2021)
Response prediction biomarkers and drug combinations of PARP inhibitors in prostate cancer
Yi-xin Chen et al.
ACTA PHARMACOLOGICA SINICA (2021)
Genomic landscape of advanced prostate cancer in racial minority populations: Real-world experience in a safety-net hospital oncology clinic.
Tamer Khashab et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?
Bruce N. Ames et al.
NUTRIENTS (2021)
Trackling Diversity in Prostate Cancer Clinical Trials: A Report From the Diversity Working Group of the IRONMAN Registry
Rana R. McKay et al.
JCO GLOBAL ONCOLOGY (2021)
Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system
Paul Riviere et al.
CANCER (2020)
Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes
Christopher M. Heaphy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Tumour metabolism and its unique properties in prostate adenocarcinoma
David A. Bader et al.
NATURE REVIEWS UROLOGY (2020)
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
Oliver Sartor et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients
Junfeng Xu et al.
EBIOMEDICINE (2020)
Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
Jiao Yuan et al.
PLOS GENETICS (2020)
A genomic and epigenomic atlas of prostate cancer in Asian populations
Jing Li et al.
NATURE (2020)
Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians
Santosh Yadav et al.
ONCOGENE (2020)
Clinical development of therapies targeting TGF beta: current knowledge and future perspectives
D. Ciardiello et al.
ANNALS OF ONCOLOGY (2020)
Genomic Profiling of Prostate Cancers from Men with African and European Ancestry
Yusuke Koga et al.
CLINICAL CANCER RESEARCH (2020)
Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions
Emily M. Rencsok et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Association of Neighborhood Disadvantage in Childhood With DNA Methylation in Young Adulthood
Aaron Reuben et al.
JAMA NETWORK OPEN (2020)
Racial Differences in Genomic Profiling of Prostate Cancer
Brandon A. Mahal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association of State-Level Medicaid Expansion With Treatment of Patients With Higher-Risk Prostate Cancer
Wen Liu et al.
JAMA NETWORK OPEN (2020)
The weathering hypothesis as an explanation for racial disparities in health: a systematic review
Allana T. Forde et al.
ANNALS OF EPIDEMIOLOGY (2019)
Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines
Stanley E. Hooker et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis (vol 35, pg 603, 2019)
Michael A. Augello et al.
CANCER CELL (2019)
TMPRSS2-ERG fusions linked to prostate cancer racial health disparities: A focus on Africa
James Blackburn et al.
PROSTATE (2019)
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality
Robert T. Dess et al.
JAMA ONCOLOGY (2019)
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
Abhijit Parolia et al.
NATURE (2019)
Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity
Victor Apprey et al.
ANTICANCER RESEARCH (2019)
Racial differences in distribution of fatty acids in prostate cancer and benign prostatic tissues
Xinchun Zhou et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY
Scott T. Tagawa et al.
CLINICAL CANCER RESEARCH (2019)
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
Giorgia Zadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
Gyorgy Petrovics et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2019)
Rare germline mutations in African American men diagnosed with early-onset prostate cancer
Jennifer L. Beebe-Dimmer et al.
PROSTATE (2018)
Elevation of Stromal-Derived Mediators of Inflammation Promote Prostate Cancer Progression in African-American Men
Marc Gillard et al.
CANCER RESEARCH (2018)
Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models
Nora M. Navone et al.
PROSTATE (2018)
Prostate Cancer Outcomes for Men Aged Younger Than 65 Years With Medicaid Versus Private Insurance
Amandeep R. Mahal et al.
CANCER (2018)
Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
Bi-Dar Wang et al.
NATURE COMMUNICATIONS (2017)
Social adversity and epigenetic aging: a multi-cohort study on socioeconomic differences in peripheral blood DNA methylation
Giovanni Fiorito et al.
SCIENTIFIC REPORTS (2017)
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer
Mark M. Pomerantz et al.
CANCER (2017)
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression
Yongquan Wang et al.
CANCER RESEARCH (2017)
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
T. R. Shenoy et al.
ANNALS OF ONCOLOGY (2017)
Prostatic compensation of the vitamin D axis in African American men
Zachary Richards et al.
JCI INSIGHT (2017)
Race and BMI modify associations of calcium and vitamin D intake with prostate cancer
Ken Batai et al.
BMC CANCER (2017)
MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
Li Zhang et al.
CANCER RESEARCH (2016)
Oxidative guanine base damage regulates human telomerase activity
Elise Fouquerel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Oxidative guanine base damage regulates human telomerase activity
Elise Fouquerel et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Biological marks of early-life socioeconomic experience is detected in the adult inflammatory transcriptome
Raphaele Castagne et al.
SCIENTIFIC REPORTS (2016)
Racial Discrimination, John Henryism, and Depression Among African Americans
Darrell L. Hudson et al.
JOURNAL OF BLACK PSYCHOLOGY (2016)
The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions
Scarlett Lin Gomez et al.
CANCER (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system
T. J. Daskivich et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2015)
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Wendy E. Barrington et al.
JAMA ONCOLOGY (2015)
Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
Chuandong Geng et al.
CANCER RESEARCH (2014)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Vitamin D Deficiency Predicts Prostate Biopsy Outcomes
Adam B. Murphy et al.
CLINICAL CANCER RESEARCH (2014)
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Giorgia Zadra et al.
EMBO MOLECULAR MEDICINE (2014)
Androgen Receptor Mutations and Polymorphisms in African American Prostate Cancer
Shahriar Koochekpour et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis
A. Richard et al.
ANDROLOGY (2014)
The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer
Cynthia C. T. Sprenger et al.
HORMONES & CANCER (2014)
SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
Mirjam Blattner et al.
NEOPLASIA (2014)
Agent Orange as a risk factor for high-grade prostate cancer
Nathan Ansbaugh et al.
CANCER (2013)
Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men
Isaac J. Powell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Elevated polycyclic aromatic hydrocarbonDNA adducts in benign prostate and risk of prostate cancer in African Americans
Deliang Tang et al.
CARCINOGENESIS (2013)
Biological determinants of health disparities in prostate cancer
Damali N. Martin et al.
CURRENT OPINION IN ONCOLOGY (2013)
Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
Rhonda L. Bitting et al.
ENDOCRINE-RELATED CANCER (2013)
Vitamin D3 supplementation, low-risk prostate cancer, and health disparities
Bruce W. Hollis et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover
Chuandong Geng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
Wen-Chin Huang et al.
MOLECULAR CANCER RESEARCH (2012)
Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence
Graeme Hewitt et al.
NATURE COMMUNICATIONS (2012)
Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men
H. S. Kim et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
A Retrospective Study on Pathologic Features and Racial Disparities in Prostate Cancer
Steven A. Bigler et al.
PROSTATE CANCER (2011)
Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity
Isaac J. Powell et al.
JOURNAL OF UROLOGY (2010)
Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity
Nora L. Nock et al.
CANCER CAUSES & CONTROL (2009)
Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California
Iona Cheng et al.
CANCER CAUSES & CONTROL (2009)
Cancer Incidence in the US Military Population: Comparison with Rates from the SEER Program
Kangmin Zhu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Racial Differences in Risk of Prostate Cancer Associated With Metabolic Syndrome
Jennifer L. Beebe-Dimmer et al.
UROLOGY (2009)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Association of Megalin genetic polymorphisms with prostate cancer risk and prognosis
Sarah K. Holt et al.
CLINICAL CANCER RESEARCH (2008)
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
Jing Jiao et al.
CANCER RESEARCH (2007)
Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s
AD Berger et al.
UROLOGY (2006)
Factors contributing to the racial differences in prostate cancer mortality
A Tewari et al.
BJU INTERNATIONAL (2005)
Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
N Gao et al.
DEVELOPMENT (2005)
The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy
IJ Powell et al.
CANCER (2005)
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy
CL Amling et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer
KE Gaston et al.
JOURNAL OF UROLOGY (2003)
Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status
CL Bennett et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Changing relationship between socioeconsmic status and prostate cancer incidence
LH Liu et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
